{"id":9950,"date":"2024-10-18T07:19:52","date_gmt":"2024-10-18T07:19:52","guid":{"rendered":"https:\/\/resemedicin.se\/reseradet\/?p=9950"},"modified":"2024-10-28T07:16:39","modified_gmt":"2024-10-28T07:16:39","slug":"2024-10-18-nya-brittiska-rekommendationer-om-qdenga","status":"publish","type":"post","link":"https:\/\/resemedicin.se\/reseradet\/nyheter\/2024-10-18-nya-brittiska-rekommendationer-om-qdenga\/","title":{"rendered":"2024-10-18 Nya brittiska rekommendationer om Qdenga\u00ae"},"content":{"rendered":"\n<h3 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-a8ffddd38e2e744eacaaac115987c3a2\" style=\"background-color:#2b7c08\">H\u00e4ndelse<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Brittiska UK Health Security Agency\u00a0och dess Joint Committee on Vaccination and Immunisation (JCVI) har nu publicerat sina l\u00e4nge aviserade <a href=\"https:\/\/travelhealthpro.org.uk\/media_lib\/mlib-uploads\/full\/the-green-book-chapter-15a-dengue-october-2024.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">rekommendationer r\u00f6rande vaccination mot denguefeber<\/a>. I sina nya rekommendationer betonar man att nyttan av att vaccinera resen\u00e4rer \u00e4r att f\u00f6rhindra allvarlig infektion hos personer som tidigare haft dengue, men man avr\u00e5der fr\u00e5n att vaccinera individer som inte tidigare haft dengue, med anledning av m\u00f6jlig risk f\u00f6r sv\u00e5rare infektion om senare smittad med denguevirus 3 och 4.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Man skriver (v\u00e5r \u00f6vers\u00e4ttning): &#8221;Qdenga\u00ae-vaccinet rekommenderas inte f\u00f6r seronegativa individer (dvs. de som inte har n\u00e5gra tecken p\u00e5 tidigare dengueinfektion (&#8230;). F\u00f6rs\u00f6ksdata \u00e4r f\u00f6r n\u00e4rvarande otillr\u00e4ckliga f\u00f6r att ge en rekommendation f\u00f6r dessa individer. JCVI har vidtagit en f\u00f6rsiktighetsstrategi f\u00f6r sina r\u00e5d till brittiska resen\u00e4rer, p\u00e5 grund av en teoretisk risk f\u00f6r sv\u00e5r denguefeber om en seronegativ individ vaccineras och d\u00e4refter exponeras f\u00f6r denguevirus DENV3 eller DENV4.&#8221;<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-white-color has-text-color has-background has-link-color wp-elements-f54cfb83e9d133aede8411599e2c0006\" style=\"background-color:#2b7c08\">Bed\u00f6mning och rekommendationer<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">De brittiska rekommendationerna \u00e4r i linje med dem fr\u00e5n <a href=\"https:\/\/infektion.net\/kunskap\/vagledning-for-vaccination-med-qdenga-till-svenska-resenarer\/\">svenska infektionsl\u00e4karf\u00f6reningen<\/a> och <a href=\"https:\/\/iris.who.int\/bitstream\/handle\/10665\/376641\/WER9918-eng-fre.pdf?sequence=1\">WHO<\/a> i att betona den m\u00f6jliga risken f\u00f6r sv\u00e5rare infektion med DENV3 och DENV4 hos tidigare seronegativa individer som vaccinerats. \u00c4ven Reser\u00e5det har f\u00f6rordat en viss f\u00f6rsiktighetsprincip i v\u00e5ra vaccinrekommendationer \u00e4ven om vi inte g\u00f6r en total avr\u00e5dan f\u00f6r vaccination av seronegativa individer s\u00e5som v\u00e5ra brittiska kollegor..<\/p>\n","protected":false},"excerpt":{"rendered":"<p>H\u00e4ndelse Brittiska UK Health Security Agency\u00a0och dess Joint Committee on Vaccination and Immunisation (JCVI) har nu publicerat sina l\u00e4nge aviserade rekommendationer r\u00f6rande vaccination mot denguefeber. I sina nya rekommendationer betonar man att nyttan av att vaccinera resen\u00e4rer \u00e4r att f\u00f6rhindra allvarlig infektion hos personer som tidigare haft dengue, men man avr\u00e5der fr\u00e5n att vaccinera individer &hellip; <a href=\"https:\/\/resemedicin.se\/reseradet\/nyheter\/2024-10-18-nya-brittiska-rekommendationer-om-qdenga\/\" class=\"more-link\">Forts\u00e4tt l\u00e4sa<span class=\"screen-reader-text\"> \u201d2024-10-18 Nya brittiska rekommendationer om Qdenga\u00ae\u201d<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-9950","post","type-post","status-publish","format-aside","hentry","category-nyheter","post_format-post-format-aside"],"modified_by":"Reser\u00e5det","jetpack_featured_media_url":"","jetpack-related-posts":[{"id":15381,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-12-01-uppdaterade-rekommendationer-rorande-vaccination-mot-denguefeber\/","url_meta":{"origin":9950,"position":0},"title":"2025-12-01 Uppdaterade rekommendationer r\u00f6rande vaccination mot denguefeber","author":"Reser\u00e5det","date":"2025-12-01","format":"aside","excerpt":"Allm\u00e4nt resonemang Vaccinet mot denguefeber, Qdenga\u00ae, \u00e4r fr\u00e4mst framtaget f\u00f6r att skydda barn i endemiska l\u00e4nder. Att f\u00e5 denguefeber en andra g\u00e5ng \u00e4r en riskfaktor f\u00f6r sv\u00e5rare sjukdom. Orsaken till detta \u00e4r inte helt klarlagd. F\u00f6r Dengvaxia\u00ae, ett tidigare denguevaccin, har man sett en \u00f6kad risk f\u00f6r sv\u00e5rare sjukdom hos\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/12\/image-5-scaled.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/12\/image-5-scaled.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/12\/image-5-scaled.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/12\/image-5-scaled.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/12\/image-5-scaled.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2025\/12\/image-5-scaled.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":12201,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2024-11-25-denguefeber-global-oversikt\/","url_meta":{"origin":9950,"position":1},"title":"2024-11-25 Denguefeber, global \u00f6versikt","author":"Reser\u00e5det","date":"2024-11-25","format":"aside","excerpt":"ECDC har uppdaterat karta och statistik \u00f6ver den globala situationen f\u00f6r denguefeber. Den \u00f6kning som f\u00f6rst noterades 2023 har fortsatt 2024. V\u00e4rst \u00e4r situationen i Mellan- och Sydamerika. En h\u00f6g andel av fallen orsakas av DENV3 som Qdenga har d\u00e5lig vaccineffekt mot. I Asien rapporterades f\u00f6r f\u00f6rsta g\u00e5ngen inhemska fall\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14575,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-07-20-okning-av-dengue-i-vastra-stillahavsregionen\/","url_meta":{"origin":9950,"position":2},"title":"2025-07-20 \u00d6kning av dengue i v\u00e4stra Stillahavsregionen","author":"Reser\u00e5det","date":"2025-07-20","format":"aside","excerpt":"Flera \u00f6nationer i v\u00e4stra Stilla Havet, d\u00e4ribland Amerikanska Samoa, Australien, Cook\u00f6arna, Franska Polynesien, Nya Zeeland, Samoa, Tonga och Tuvalu har de senaste m\u00e5naderna rapporterat utbrott av denguefeber. I b\u00f6rjan av juli f\u00f6rklarade Amerikanska Samoas h\u00e4lsodepartement det p\u00e5g\u00e5ende dengueutbrottet i landet som en folkh\u00e4lsokris, med DENV-1 och DENV-2 som dominerande serotyper.\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15960,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2026-02-16-ixchiq-uppdaterade-rekommendationer\/","url_meta":{"origin":9950,"position":3},"title":"2026-02-16 IXCHIQ\u00ae \u2013 uppdaterade rekommendationer","author":"Reser\u00e5det","date":"2026-02-16","format":"aside","excerpt":"Den brittiska l\u00e4kemedelsmyndigheten\u00a0Medicines and Healthcare products Regulatory Agency (MHRA)\u00a0har efter en s\u00e4kerhetsgenomg\u00e5ng inf\u00f6rt sk\u00e4rpta restriktioner f\u00f6r anv\u00e4ndning av det levande, f\u00f6rsvagade chikungunyavaccinet IXCHIQ\u00ae. Enligt de uppdaterade rekommendationerna ska vaccinet: inte anv\u00e4ndas hos personer \u226560 \u00e5r, och \u00e4r nu\u00a0kontraindicerat oavsett \u00e5lder\u00a0hos personer med\u00a0hypertension, kardiovaskul\u00e4r sjukdom, diabetes mellitus och\/eller kronisk njursjukdom. Bakgrunden\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15880,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2026-01-25-uppdaterade-rekommendationer-om-pneumokockvaccination-till-riskgrupper\/","url_meta":{"origin":9950,"position":4},"title":"2026-01-25 Uppdaterade rekommendationer om pneumokockvaccination till riskgrupper","author":"Reser\u00e5det","date":"2026-01-25","format":"aside","excerpt":"Folkh\u00e4lsomyndigheten har nyligen\u00a0uppdaterat sina rekommendationer om pneumokockvaccination till riskgrupper. Den viktigaste nyheten i den uppdaterade versionen \u00e4r att\u00a0alla riskgrupper nu rekommenderas vaccination med konjugerat pneumokockvaccin. F\u00f6r personer i riskgrupper rekommenderas konjugatvaccin som inneh\u00e5ller\u00a0minst 20 serotyper. F\u00f6r vuxna finns i dag tv\u00e5 s\u00e5dana vacciner godk\u00e4nda: ett 20-valent (PCV20, Prevenar 20\u00ae), och\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/resemedicin.se\/reseradet\/wp-content\/uploads\/2026\/01\/image-5.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":14592,"url":"https:\/\/resemedicin.se\/reseradet\/epinytt\/2025-07-20-utbrott-av-denguefeber-ho-chi-minh-city-vietnam\/","url_meta":{"origin":9950,"position":5},"title":"2025-07-20 Utbrott av denguefeber, Ho Chi Minh City, Vietnam","author":"Reser\u00e5det","date":"2025-07-20","format":"aside","excerpt":"H\u00e4lsov\u00e5rdsmyndigheterna i Ho Chi Minh City (HCMC), Vietnam, har utf\u00e4rdat en akut varning p.g.a. ett st\u00f6rre utbrott av denguefeber. Under \u00e5rets sex f\u00f6rsta m\u00e5nader har 14 730 fall, inklusive sex d\u00f6dsfall, rapporterats i staden - en drygt 150% \u00f6kning j\u00e4mf\u00f6rt med motsvarande period 2024. Det stora flertalet av infektionerna (>\u2026","rel":"","context":"I \u201dEpiNytt\u201d","block_context":{"text":"EpiNytt","link":"https:\/\/resemedicin.se\/reseradet\/kategori\/epinytt\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/posts\/9950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/comments?post=9950"}],"version-history":[{"count":11,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/posts\/9950\/revisions"}],"predecessor-version":[{"id":10897,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/posts\/9950\/revisions\/10897"}],"wp:attachment":[{"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/media?parent=9950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/categories?post=9950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/resemedicin.se\/reseradet\/wp-json\/wp\/v2\/tags?post=9950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}